EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Peptide Nucleic Acid Probes for Pretargeted Affibody-Mediated Delivery of Cytotoxic Payloads to HER2-Positive Carcinoma

Jacob Clinton, Kristina Westerlund, Astrid Haraldsson, Ebba Nordén, Tilde Hagelin, Eleftherios Papalanis iD, Moeen Ud-Din, Anzhelika Vorobyeva iD, Torbjörn Gräslund iD, Amelie Eriksson Karlström iD, Maryam Oroujeni iD

Bioconjugate Chemistry · 19.08.2026 · 37 (8) · 1562-1570

DOI: 10.1021/acs.bioconjchem.6c00035 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Bioconjugate Chemistry, online erschienen am 30.07.2026. Verfasst von Jacob Clinton und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Protein Science, School of Engineering Sciences in Chemistry, Biotechnology and Health, KTH Royal Institute of Technology, Stockholm106…. Hauptthemen laut MEDLINE: Erb-b2 Receptor Tyrosine Kinases, Peptide Nucleic Acids, Drug Delivery Systems. Die Arbeit nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Cancerfonden, Svenska S?llskapet f?r Medicinsk Forskning, Knut och Alice Wallenbergs Stiftelse.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This study investigates how the structural design of secondary PNA probes affects their ability to carry the cytotoxic agent DM1 in a novel affibody-PNA-based pretargeting approach directed at Human Epidermal growth factor Receptor 2 (HER2)-expressing cells. Six different DM1-conjugated secondary 8-mer PNA probes with strategic hydrophilic modifications were designed and evaluated. Surface plasmon resonance analysis confirmed that the modifications preserved hybridization to the HER2-targeting affibody-PNA primary probe, with all secondary probes showing similar binding kinetics (KD = 310–660 pM). Biodistribution studies in nontumor-bearing NMRI mice with lutetium-177 (177Lu)-labeled secondary probes revealed that probe modifications dramatically influenced organ distribution patterns. The secondary probes SP2, SP5, and SPc demonstrated favorable biodistribution profiles with reduced accumulation in critical organs, i.e., liver and kidneys. Receptor-mediated endocytosis was also affected by secondary probe design, showing an increase in cellular internalization for SP5 (20.4% after 24 h) compared to SP2 (12.1%). Our findings highlight how rational design can optimize in vivo pharmacokinetics while preserving binding properties essential for effective pretargeting, providing a foundation for developing novel targeted cytotoxic delivery systems with potentially improved therapeutic indexes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Erb-b2 Receptor Tyrosine KinasesPeptide Nucleic AcidsDrug Delivery SystemsHumansAnimalsMiceTissue DistributionCell Line, TumorFemaleLutetium

Substanzen

Erb-b2 Receptor Tyrosine KinasesPeptide Nucleic AcidsERBB2 protein, humanLutetium

Autor:innen und Institutionen

  • Department of Protein Science, School of Engineering Sciences in Chemistry, Biotechnology and Health, KTH Royal Institute of Technology, Stockholm10691, Sweden.
  • Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala75185, Sweden.

ORCID-Profile: Eleftherios Papalanis, Anzhelika Vorobyeva, Torbjörn Gräslund, Amelie Eriksson Karlström, Maryam Oroujeni

Förderung

  • Cancerfonden
  • Svenska S?llskapet f?r Medicinsk Forskning
  • Knut och Alice Wallenbergs Stiftelse
  • Swedish Research Council (VR)

Zitieren

APA

Clinton, J., Westerlund, K., Haraldsson, A., Nordén, E., Hagelin, T., Papalanis, E., Ud-Din, M., Vorobyeva, A., Gräslund, T., Eriksson Karlström, A., & Oroujeni, M. (2026). Peptide Nucleic Acid Probes for Pretargeted Affibody-Mediated Delivery of Cytotoxic Payloads to HER2-Positive Carcinoma. Bioconjugate Chemistry, 37(8), 1562-1570. https://doi.org/10.1021/acs.bioconjchem.6c00035

Vancouver

Clinton J, Westerlund K, Haraldsson A, Nordén E, Hagelin T, Papalanis E, et al. Peptide Nucleic Acid Probes for Pretargeted Affibody-Mediated Delivery of Cytotoxic Payloads to HER2-Positive Carcinoma. Bioconjugate Chemistry. 2026;37(8):1562-1570. doi:10.1021/acs.bioconjchem.6c00035

BibTeX
@article{Clinton2026,
  author = {Clinton, Jacob and Westerlund, Kristina and Haraldsson, Astrid and Nordén, Ebba and Hagelin, Tilde and Papalanis, Eleftherios and Ud-Din, Moeen and Vorobyeva, Anzhelika and Gräslund, Torbjörn and Eriksson Karlström, Amelie and Oroujeni, Maryam},
  title = {Peptide Nucleic Acid Probes for Pretargeted Affibody-Mediated Delivery of Cytotoxic Payloads to HER2-Positive Carcinoma},
  journal = {Bioconjugate Chemistry},
  year = {2026},
  volume = {37},
  number = {8},
  pages = {1562--1570},
  doi = {10.1021/acs.bioconjchem.6c00035}
}
Kostenlos starten →